81 related articles for article (PubMed ID: 10974941)
21. [Domain-specific subjective quality of life and illness-related limitations of chronic schizophrenic patients].
Lauer G; Stegmüller-Koenemund U
Psychiatr Prax; 1994 Mar; 21(2):70-3. PubMed ID: 7910973
[TBL] [Abstract][Full Text] [Related]
22. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
23. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
24. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
Putzhammer A; Perfahl M; Pfeiff L; Hajak G
Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
26. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
[TBL] [Abstract][Full Text] [Related]
27. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
28. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R;
Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312
[TBL] [Abstract][Full Text] [Related]
29. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
[TBL] [Abstract][Full Text] [Related]
30. [Cortical atrophy in MRI, mental status and neuroleptic treatment effect in schizophrenia].
Jarema M; Choma M; Kozłowski P; Poniatowska R; Krawczyk R
Psychiatr Pol; 1997; 31(5):547-57. PubMed ID: 9547181
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of quality of life of schizophrenic patients in different forms of psychiatric care].
Jarema M; Bury L; Konieczyńska Z; Zaborowski B; Cikowska G; Kunicka A; Bartoszewicz J; Muraszkiewicz L
Psychiatr Pol; 1997; 31(5):585-94. PubMed ID: 9547184
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of quality of life in patients with cancer].
Jarema A
Psychiatr Pol; 1997; 31(3):333-43. PubMed ID: 9527678
[TBL] [Abstract][Full Text] [Related]
33. Quality of life measurement during antipsychotic drug therapy of schizophrenia.
Voruganti LN; Heslegrave RJ; Awad AG
J Psychiatry Neurosci; 1997 Jul; 22(4):267-74. PubMed ID: 9262049
[TBL] [Abstract][Full Text] [Related]
34. [Comparative evaluation of quality of life in patients with schizophrenia treated with conventional versus atypical neuroleptics: results of a transversal study].
Divanon F; Delamillieure P; Lehaguez A; Vasse T; Morello R; Gourevitch R; Langlois S; Assouly-Besse F; Guelfi JD; Petit M; Dollfus S
Encephale; 2006; 32(4 Pt 1):459-65. PubMed ID: 17099557
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between perazine serum concentration and clinical results in long-term treated schizophrenic outpatients (author's transl)].
Pietzcker A; Müller-Oerlinghausen B; Schley J; Chaskel H; Poppenberg A; Urban R
Arzneimittelforschung; 1978; 28(8):1302-3. PubMed ID: 37850
[TBL] [Abstract][Full Text] [Related]
36. [The preliminary evaluation of quality of life in patients with chronic schizophrenia].
Główczak M; Kasperek B; Meder J; Spiridonow K
Psychiatr Pol; 1997; 31(3):313-21. PubMed ID: 9527676
[TBL] [Abstract][Full Text] [Related]
37. [Transversal study of the psychosocial rehabilitation and the quality of life of 75 schizophrenics under classical neuroleptics or atypical antipsychotic neuroleptics].
Guillard-Bouhet N; Lafay N; Jourdain M; Senon JL
Encephale; 2005; 31(6 Pt 1):653-65. PubMed ID: 16462684
[TBL] [Abstract][Full Text] [Related]
38. Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients.
Squelart P; Saravia J
Acta Psychiatr Belg; 1977; 77(2):284-93. PubMed ID: 906888
[TBL] [Abstract][Full Text] [Related]
39. Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients.
Zhang PL; Santos JM; Newcomer J; Pelfrey BA; Johnson MC; de Erausquin GA
Schizophr Res; 2004 Nov; 71(1):137-44. PubMed ID: 15374581
[TBL] [Abstract][Full Text] [Related]
40. The histamine test in schizophrenia.
Aggernaes H; Schultz V; Bjørum N
J Clin Psychiatry; 1982 Dec; 43(12):479-80. PubMed ID: 6131063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
